12/4
08:53 pm
bmy
Bristol Myers Squibb's Breyanzi Approved by the U.S. FDA as the First and Only CAR T Cell Therapy for Adults with Relapsed or Refractory Marginal Zone Lymphoma (MZL) [Yahoo! Finance]
Low
Report
Bristol Myers Squibb's Breyanzi Approved by the U.S. FDA as the First and Only CAR T Cell Therapy for Adults with Relapsed or Refractory Marginal Zone Lymphoma (MZL) [Yahoo! Finance]
12/4
08:15 pm
bmy
Bristol Myers Squibb’s Breyanzi Approved by the U.S. FDA as the First and Only CAR T Cell Therapy for Adults with Relapsed or Refractory Marginal Zone Lymphoma (MZL)
Low
Report
Bristol Myers Squibb’s Breyanzi Approved by the U.S. FDA as the First and Only CAR T Cell Therapy for Adults with Relapsed or Refractory Marginal Zone Lymphoma (MZL)
12/4
08:45 am
bmy
Bristol Myers Squibb (NYSE:BMY) had its "sector perform" rating reaffirmed by analysts at Scotiabank.
Low
Report
Bristol Myers Squibb (NYSE:BMY) had its "sector perform" rating reaffirmed by analysts at Scotiabank.
12/4
12:08 am
bmy
How faster decisions can transform patient care in Canada [Globe and Mail, The (Toronto, Canada)]
Low
Report
How faster decisions can transform patient care in Canada [Globe and Mail, The (Toronto, Canada)]
12/3
04:14 pm
bmy
Bristol Myers Squibb (NYSE:BMY) was given a new $65.00 price target on by analysts at Truist Financial Corporation.
Low
Report
Bristol Myers Squibb (NYSE:BMY) was given a new $65.00 price target on by analysts at Truist Financial Corporation.
12/3
11:00 am
bmy
Terray Therapeutics Achieves AI-Enabled Drug Discovery Milestone in Collaboration with Bristol Myers Squibb
Low
Report
Terray Therapeutics Achieves AI-Enabled Drug Discovery Milestone in Collaboration with Bristol Myers Squibb
12/3
06:59 am
bmy
Bristol Myers Squibb Announces Continuation of ADEPT-2 Phase 3 Study in Psychosis Associated with Alzheimer's Disease
Medium
Report
Bristol Myers Squibb Announces Continuation of ADEPT-2 Phase 3 Study in Psychosis Associated with Alzheimer's Disease
12/3
02:06 am
bmy
Cantor Fitzgerald Maintains Price Target on Bristol-Myers (BMY) Amid Milvexian Updates [Yahoo! Finance]
Medium
Report
Cantor Fitzgerald Maintains Price Target on Bristol-Myers (BMY) Amid Milvexian Updates [Yahoo! Finance]
12/2
07:10 am
bmy
Bristol Myers Squibb (NYSE:BMY) had its "neutral" rating reaffirmed by analysts at The Goldman Sachs Group, Inc..
Low
Report
Bristol Myers Squibb (NYSE:BMY) had its "neutral" rating reaffirmed by analysts at The Goldman Sachs Group, Inc..
12/1
04:59 pm
bmy
Bristol Myers must face $6.7 billion lawsuit over delayed cancer drug, US judge rules [Yahoo! Finance]
Low
Report
Bristol Myers must face $6.7 billion lawsuit over delayed cancer drug, US judge rules [Yahoo! Finance]
12/1
10:10 am
bmy
What Is Happening With BMY Stock? [Forbes]
Low
Report
What Is Happening With BMY Stock? [Forbes]
12/1
06:59 am
bmy
Bristol Myers Squibb Data at ASH 2025 Showcase Potential of Hematology Pipeline and Build Momentum for Next Generation Portfolio
Low
Report
Bristol Myers Squibb Data at ASH 2025 Showcase Potential of Hematology Pipeline and Build Momentum for Next Generation Portfolio
11/30
07:37 pm
bmy
BioNTech (BNTX) Is Up 7.9% After Raising 2025 Revenue Guidance on Bristol-Myers Collaboration [Yahoo! Finance]
Low
Report
BioNTech (BNTX) Is Up 7.9% After Raising 2025 Revenue Guidance on Bristol-Myers Collaboration [Yahoo! Finance]
11/28
07:11 pm
bmy
Bristol-Myers Squibb Company (BMY): A Bull Case Theory [Yahoo! Finance]
Low
Report
Bristol-Myers Squibb Company (BMY): A Bull Case Theory [Yahoo! Finance]
11/28
10:52 am
bmy
Bristol Myers (BMY) Gains EU Approval for Breyanzi in Mantle Cell Lymphoma—What Does This Mean? [Yahoo! Finance]
Low
Report
Bristol Myers (BMY) Gains EU Approval for Breyanzi in Mantle Cell Lymphoma—What Does This Mean? [Yahoo! Finance]
11/28
09:29 am
bmy
Bristol-Myers Squibb Surges 15% After Drug Approvals: Is the Stock a Bargain in 2025? [Yahoo! Finance]
Low
Report
Bristol-Myers Squibb Surges 15% After Drug Approvals: Is the Stock a Bargain in 2025? [Yahoo! Finance]
11/28
04:32 am
bmy
????????????·??????:??????????(2025-2035?) [CNET News]
Low
Report
????????????·??????:??????????(2025-2035?) [CNET News]
11/26
07:36 am
bmy
Bristol Myers Squibb to Participate in Citi's 2025 Global Healthcare Conference [Yahoo! Finance]
Low
Report
Bristol Myers Squibb to Participate in Citi's 2025 Global Healthcare Conference [Yahoo! Finance]
11/26
06:59 am
bmy
Bristol Myers Squibb to Participate in Citi’s 2025 Global Healthcare Conference
Low
Report
Bristol Myers Squibb to Participate in Citi’s 2025 Global Healthcare Conference
11/24
05:00 pm
bmy
Bristol Myers Squibb Receives Approval from the European Commission to Expand Use of CAR T Cell Therapy Breyanzi for Relapsed or Refractory Mantle Cell Lymphoma
Low
Report
Bristol Myers Squibb Receives Approval from the European Commission to Expand Use of CAR T Cell Therapy Breyanzi for Relapsed or Refractory Mantle Cell Lymphoma
11/24
09:07 am
bmy
Bristol Myers Squibb (NYSE:BMY) had its "neutral" rating reaffirmed by analysts at Cantor Fitzgerald.
Low
Report
Bristol Myers Squibb (NYSE:BMY) had its "neutral" rating reaffirmed by analysts at Cantor Fitzgerald.
11/24
06:59 am
bmy
Bristol Myers Squibb to Host Hematology-Focused Investor Event
Low
Report
Bristol Myers Squibb to Host Hematology-Focused Investor Event
11/21
06:11 pm
bmy
This Drugmaker Is Too Cheap to Ignore. Why Bristol Is a Buy. [Yahoo! Finance]
Low
Report
This Drugmaker Is Too Cheap to Ignore. Why Bristol Is a Buy. [Yahoo! Finance]
11/21
10:29 am
bmy
The Melanoma Research Foundation Launches its Inaugural Tampa Bay 5K Fundraiser with a Goal of $30,000 in Support of its Mission
Low
Report
The Melanoma Research Foundation Launches its Inaugural Tampa Bay 5K Fundraiser with a Goal of $30,000 in Support of its Mission
11/21
08:01 am
bmy
Bristol-Myers Squibb: I See No Catalysts To Break Underperformance [Seeking Alpha]
Low
Report
Bristol-Myers Squibb: I See No Catalysts To Break Underperformance [Seeking Alpha]